Operating Income (Loss) in USD of Inmune Bio, Inc. from 2017 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Inmune Bio, Inc. quarterly/annual Operating Income (Loss) history and change rate from 2017 to Q3 2025.
  • Inmune Bio, Inc. Operating Income (Loss) for the quarter ending 30 Sep 2025 was -$7.43M, a 39.5% increase year-over-year.
  • Inmune Bio, Inc. Operating Income (Loss) for the twelve months ending 30 Sep 2025 was -$51.4M, a 23.7% decline year-over-year.
  • Inmune Bio, Inc. annual Operating Income (Loss) for 2024 was -$42.6M, a 43.4% decline from 2023.
  • Inmune Bio, Inc. annual Operating Income (Loss) for 2023 was -$29.7M, a 14.6% decline from 2022.
  • Inmune Bio, Inc. annual Operating Income (Loss) for 2022 was -$26M, a 11% increase from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

Inmune Bio, Inc. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$51.4M -$7.43M +$4.85M +39.5% 01 Jul 2025 30 Sep 2025 10-Q 30 Oct 2025
Q2 2025 -$56.2M -$24.6M -$14.7M -149% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025
Q1 2025 -$41.5M -$9.91M +$1.11M +10.1% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025
Q4 2024 -$42.6M -$9.47M -$1.09M -13% 01 Oct 2024 31 Dec 2024 10-K 27 Mar 2025
Q3 2024 -$41.5M -$12.3M -$3.76M -44.1% 01 Jul 2024 30 Sep 2024 10-Q 30 Oct 2025
Q2 2024 -$37.8M -$9.87M -$3.45M -53.9% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025
Q1 2024 -$34.3M -$11M -$4.59M -71.5% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025
Q4 2023 -$29.7M -$8.38M -$2.74M -48.5% 01 Oct 2023 31 Dec 2023 10-K 27 Mar 2025
Q3 2023 -$27M -$8.53M -$1.09M -14.6% 01 Jul 2023 30 Sep 2023 10-Q 31 Oct 2024
Q2 2023 -$25.9M -$6.41M -$23K -0.36% 01 Apr 2023 30 Jun 2023 10-Q 01 Aug 2024
Q1 2023 -$25.9M -$6.42M +$55K +0.85% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024
Q4 2022 -$26M -$5.64M +$3.39M +37.5% 01 Oct 2022 31 Dec 2022 10-K 28 Mar 2024
Q3 2022 -$29.3M -$7.44M +$1.58M +17.5% 01 Jul 2022 30 Sep 2022 10-Q 01 Nov 2023
Q2 2022 -$30.9M -$6.39M +$166K +2.53% 01 Apr 2022 30 Jun 2022 10-Q 07 Aug 2023
Q1 2022 -$31.1M -$6.48M -$1.93M -42.4% 01 Jan 2022 31 Mar 2022 10-Q 03 May 2023
Q4 2021 -$29.2M -$9.03M -$5.82M -181% 01 Oct 2021 31 Dec 2021 10-K 02 Mar 2023
Q3 2021 -$23.3M -$9.02M -$4.2M -87.2% 01 Jul 2021 30 Sep 2021 10-Q 02 Nov 2022
Q2 2021 -$19.1M -$6.55M -$4.45M -211% 01 Apr 2021 30 Jun 2021 10-Q 03 Aug 2022
Q1 2021 -$14.7M -$4.55M -$2.46M -117% 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022
Q4 2020 -$12.2M -$3.21M -$877K -37.6% 01 Oct 2020 31 Dec 2020 10-K 03 Mar 2022
Q3 2020 -$11.4M -$4.82M -$1.74M -56.3% 01 Jul 2020 30 Sep 2020 10-Q 03 Nov 2021
Q2 2020 -$9.62M -$2.11M -$1.68M -392% 01 Apr 2020 30 Jun 2020 10-Q 04 Aug 2021
Q1 2020 -$7.94M -$2.09M -$181K -9.47% 01 Jan 2020 31 Mar 2020 10-Q 05 May 2021
Q4 2019 -$7.76M -$2.33M -$452K -24.1% 01 Oct 2019 31 Dec 2019 10-K 04 Mar 2021
Q3 2019 -$7.3M -$3.08M -$1.54M -100% 01 Jul 2019 30 Sep 2019 10-Q 05 Nov 2020
Q2 2019 -$5.76M -$428K +$5.75M +93.1% 01 Apr 2019 30 Jun 2019 10-Q 05 Aug 2020
Q1 2019 -$11.5M -$1.91M +$935K +32.9% 01 Jan 2019 31 Mar 2019 10-Q 14 May 2020
Q4 2018 -$12.4M -$1.88M 01 Oct 2018 31 Dec 2018 10-K 11 Mar 2020
Q3 2018 -$1.54M 01 Jul 2018 30 Sep 2018 10-Q 08 Nov 2019
Q2 2018 -$6.17M 01 Apr 2018 30 Jun 2018 10-Q 09 Aug 2019
Q1 2018 -$2.85M 01 Jan 2018 31 Mar 2018 10-Q 15 May 2019

Inmune Bio, Inc. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$42.6M -$12.9M -43.4% 01 Jan 2024 31 Dec 2024 10-K 27 Mar 2025
2023 -$29.7M -$3.79M -14.6% 01 Jan 2023 31 Dec 2023 10-K 27 Mar 2025
2022 -$26M +$3.2M +11% 01 Jan 2022 31 Dec 2022 10-K 28 Mar 2024
2021 -$29.2M -$16.9M -138% 01 Jan 2021 31 Dec 2021 10-K 02 Mar 2023
2020 -$12.2M -$4.47M -57.7% 01 Jan 2020 31 Dec 2020 10-K 03 Mar 2022
2019 -$7.76M +$4.68M +37.7% 01 Jan 2019 31 Dec 2019 10-K 04 Mar 2021
2018 -$12.4M -$11.5M -1167% 01 Jan 2018 31 Dec 2018 10-K 11 Mar 2020
2017 -$981K 01 Jan 2017 31 Dec 2017 10-K 29 Mar 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.